AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $231,000 | +4.5% | 15,269 | -48.1% | 0.01% | -17.6% |
| Q2 2022 | $221,000 | +106.5% | 29,440 | +93.3% | 0.02% | +30.8% |
| Q4 2021 | $107,000 | -49.3% | 15,233 | -17.9% | 0.01% | -53.6% |
| Q3 2021 | $211,000 | -37.9% | 18,543 | -12.8% | 0.03% | -75.4% |
| Q2 2021 | $340,000 | +13.3% | 21,260 | +26.6% | 0.11% | +18.8% |
| Q1 2021 | $300,000 | +79.6% | 16,790 | +36.2% | 0.10% | +100.0% |
| Q4 2020 | $167,000 | -6.2% | 12,330 | +2.0% | 0.05% | -20.0% |
| Q2 2020 | $178,000 | -3.3% | 12,090 | -11.3% | 0.06% | -23.1% |
| Q1 2020 | $184,000 | – | 13,625 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |